Clinical Trial Search

Primary: Percentage Change in Area Under The Curve (AUC) for Blood Glucose 0-2 Hours — 301.09; 258.66; 248.63; 274.13 mmol x min/L — p=0.1146

Primary: Hospital Length of Stay — 7; 8 days

Primary: Hospital Length of Stay — 7; 8 days

Primary: Lowering of Fasting Glucose — 5.78; 5.83 mmol/l — p=>0.05

Primary: Ability of Different Screening Tests Which Can be Performed Opportunistically (During Outpatient Visits -- at Any Time of Day, Regardless of Meal Status) to Predict…

Primary: Blood Glucose Incremental Area Under the Curve — 240.5; 83.81 mM x 120 minutes

Primary: Abnormal Glucose Levels After Colonoscopic Preparation — 2; 0; 185 Participants

Primary: Differences in Blood Glucose Levels as Measured by GNS-POC, GS-POC and Venous Blood Prior to and After HBIG Injection — -3.2; 6.0; 56.6; -2.6 mg/dL — p=0.59

Primary: Change in Diabetes Distress — 0; 0.5 units on a scale

Primary: Number of Participants Diagnosed With Prediabetes or Normal Glucose, by 2 Measurements (Fasting Glucose Measurement and Glucose Measurement After a 2-hour Oral Glucose…

Primary: Disposition Index — 708; 793; 791 unitless

Primary: Changes in Systolic Blood Pressure During Initial Intralipid Infusion — 23; 13 mmHg

Primary: Percent of Subjects Outside Specified Blood Glucose (BG) Range -Estimated Versus Measured Blood Glucose — 45.80 percentage of subjects

Primary: Insulin Secretion — 48.9; 37.6; 51.8; 34.4 uU/mL

Primary: Fasting Plasma Glucose — 77.4; 77.7 mmol/L

Primary: Number of Successful Glucose Readings — 449 Number of Glucose readings in range

Primary: FVIIa — 69.7; 124.4 mU/ml

Primary: Incidence of Poor Graft Function After Kidney Transplant — 13; 22 Participants

Primary: Dario Blood Glucose Monitoring System Accuracy at High Altitude (ISO 15197:2003) — 28.6; 71.4; 100; 32.5 percentage of participants

Primary: Hemoglobin A1C at 4 Weeks — 10.5; 11.1 percentage of glycosylated hemoglobin

Primary: Evaluation of Peak and Nadir Glucose Profiles From Continuous Glucose Monitoring System (CGMS) — 8.86; 8.72; 8.80; 6.87 mmol/L

Primary: Incidence of Nosocomial Infections in the Cardiac ICU — 8.6; 9.9 infections / 1000 pt days

Primary: Hemoglobin A1c Levels — 7.1; 7.1 percent — p=0.67

Primary: Change in Serum Fructosamine in Subjects Treated With Low Dose and High Dose BTI320 Compared With Placebo — -5.2; -9.4; -8.8 umol/L — p=0.57

Primary: Diagnosis-Treatment — 31.7; 35.0; 29.1; 31.9 CPV diagnosis-treatment percentage score

Primary: Nucleus Accumbens Blood Flow — 1.13; 1.16; 1.15; 1.21 ml/g/min per ml/g/min

Primary: Body Composition — 39; 39; 37; 39 percentage

Primary: Percentage of Measurements With < 15% Error — 95.25; 100; 94.5; 100 Percentage of measures with error <15%

Primary: Glutathione Concentration — 541; 551 umol/L

Primary: Change in Flow Mediated Dilation (FMD) Between Baseline and After 2 Hour Insulin Clamp — 11.8; 11.8; 8.9; 8.95 % change